Analyst Ratings for ImmunoCellular Therapeutics (IMUC)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/11/2016 | Maxim Group | N/A | Downgrade | Hold (Buy) |
N/A (N/A) |
0.09 (0.22) |
144.44% | Details |
| 6/2/2014 | Roth/MKM » Updated 9/24/2015 |
N/A | Upgrade | Buy (Neutral) |
3.00 (N/A) |
1.35 (0.22) |
-83.7% | Details |
 |
||||||||
